TCRR
Goldman Sachs’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,765
| Closed | -$16.1K | – | 5269 |
|
|
2023
Q1 | $16.1K | Sell |
10,765
-956
| -8% | -$1.43K | ﹤0.01% | 4903 |
|
|
2022
Q4 | $11.7K | Sell |
11,721
-28,193
| -71% | -$28.2K | ﹤0.01% | 4931 |
|
|
2022
Q3 | $72K | Sell |
39,914
-43,552
| -52% | -$78.6K | ﹤0.01% | 4990 |
|
|
2022
Q2 | $242K | Sell |
83,466
-85,333
| -51% | -$247K | ﹤0.01% | 4811 |
|
|
2022
Q1 | $466K | Sell |
168,799
-173,965
| -51% | -$480K | ﹤0.01% | 4612 |
|
|
2021
Q4 | $1.6M | Buy |
342,764
+262,897
| +329% | +$1.22M | ﹤0.01% | 3656 |
|
|
2021
Q3 | $680K | Sell |
79,867
-240,070
| -75% | -$2.04M | ﹤0.01% | 4213 |
|
|
2021
Q2 | $5.25M | Sell |
319,937
-60,781
| -16% | -$998K | ﹤0.01% | 2747 |
|
|
2021
Q1 | $8.41M | Buy |
380,718
+132,700
| +54% | +$2.93M | ﹤0.01% | 2318 |
|
|
2020
Q4 | $7.67M | Buy |
248,018
+200,666
| +424% | +$6.21M | ﹤0.01% | 2214 |
|
|
2020
Q3 | $962K | Buy |
47,352
+30,684
| +184% | +$623K | ﹤0.01% | 3332 |
|
|
2020
Q2 | $256K | Buy |
+16,668
| New | +$256K | ﹤0.01% | 3892 |
|
|
2019
Q2 | – | Sell |
-56,443
| Closed | -$984K | – | 4321 |
|
|
2019
Q1 | $984K | Buy |
+56,443
| New | +$984K | ﹤0.01% | 3266 |
|